In NOD mice, inhibition of MECA-79+ HEV-like blood vessels after treatment with LTβR-Ig is associated with improved function of salivary and lacrimal glands [194, 195], suggesting that LTβR inhibition may ameliorate disease in human Sjögren’s syndrome. This evidence concerns the gene LTBR and Sjogren syndrome.